Showing 1 - 6 results of 6 for search 'Torsten Schaller', query time: 0.03s Refine Results
  1. 1
    SAMHD1 is a barrier to antimetabolite-based cancer therapies

    SAMHD1 is a barrier to antimetabolite-based cancer therapies by Sean G. Rudd, Torsten Schaller, Nikolas Herold

    Published 2017-03-01
    Get full text
    Article
  2. 2
    Conversion of Ultrasmall Glutathione-Coated Silver Nanoparticles during Dispersion in Water into Ultrasmall Silver Sulfide Nanoparticles

    Conversion of Ultrasmall Glutathione-Coated Silver Nanoparticles during Dispersion in Water into Ultrasmall Silver Sulfide Nanoparticles by Natalie Wolff, Oleg Prymak, Nataniel Białas, Torsten Schaller, Kateryna Loza, Felix Niemeyer, Marc Heggen, Claudia Weidenthaler, Cristiano L. P. Oliveira, Matthias Epple

    Published 2024-09-01
    Get full text
    Article
  3. 3
    CPSF6 defines a conserved capsid interface that modulates HIV-1 replication.

    CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. by Amanda J Price, Adam J Fletcher, Torsten Schaller, Tom Elliott, KyeongEun Lee, Vineet N KewalRamani, Jason W Chin, Greg J Towers, Leo C James

    Published 2012-01-01
    Get full text
    Article
  4. 4
    Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus

    Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus by Narges Seyfizadeh, David Kalbermatter, Thomas Imhof, Moritz Ries, Christian Müller, Leonie Jenner, Elisabeth Blumenschein, Alexandra Yendrzheyevskiy, Frank Grün, Kevin Moog, Daniel Eckert, Ronja Engel, Philipp Diebolder, Mohamed Chami, Jürgen Krauss, Torsten Schaller, Michaela Arndt

    Published 2024-05-01
    Get full text
    Article
  5. 5
    First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers

    First‐in‐human, randomized, double‐blind, placebo‐controlled, dose escalation trial of the anti‐herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers by Antje Blank, Nicolas Hohmann, Marlen Dettmer, Anette Manka‐Stuhlik, Gerd Mikus, Felicitas Stoll, Marlies Stützle‐Schnetz, Daniel Thomas, Evelyn Exner, Beate Schmitt‐Bormann, Torsten Schaller, Rico Laage, Oliver Schönborn‐Kellenberger, Michaela Arndt, Walter E. Haefeli, Jürgen Krauss

    Published 2022-10-01
    Get full text
    Article
  6. 6
    Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy

    Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy by Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia BJ Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman‐Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan‐Inge Henter, Torsten Schaller, Thomas Helleday, Nikolas Herold

    Published 2020-01-01
    Get full text
    Article

Search Tools: